Shivkant Patel, Piyushkumar Sadhu, Mamta Kumari, Dillip Kumar Dash, Surabhi Jain, Ashim Kumar Sen

A-Review on Anticancer Agents: Conventional Drugs and Novel Target Specific Inhibitors

  • Drug Discovery
  • Environmental Chemistry
  • Biochemistry
  • General Chemistry
Save to CiteDrive Show PDF

The second-most common reason for death globally and a significant issue for human health is cancer. The focus of the current review is to discuss cancer treatment and issues with anti-cancer medications. Nearly all cell types can develop cancer, a very varied group of approximately 200 illnesses with at least one factor in common “uncontrolled cellular development” that results in aberrant cell proliferation. In solid tumors, cancerous cells may remain localized or in situ at the location of the initial lesion, or they may become locally progressed or metastatic to distant site. Ninety percent of all cancer-related fatalities are due to by metastasis. It is the primary determinant of whether malignancy is high-risk, requiring aggressive treatment, or low-risk, curable by active surveillance, surgical removal, or adjuvant therapy. Recent advancements in computational drug discovery methodologies have not only produced important insights into the field of cancer therapy but have also had a significant and impact on the development of novel anticancer medications. Within the scope of this review, we investigated potential therapeutic targets for anti-cancer drugs.

Need a simple solution for managing your BibTeX entries? Explore CiteDrive!

  • Web-based, modern reference management
  • Collaborate and share with fellow researchers
  • Integration with Overleaf
  • Comprehensive BibTeX/BibLaTeX support
  • Save articles and websites directly from your browser
  • Search for new articles from a database of tens of millions of references
Try out CiteDrive

More from our Archive